Gene · 3357
Papers2,210
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,210
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction to Teratogenic Effects of Serotonin Receptor 2B Disruption on the Migration and Cardiac Derivatives of the Cardiac Neural Crest. | Birth Defects Res | 2025 | 40916914 | PubTator, text mining | PubMed |
| Gastric Inflammation Impacts Serotonin Secretion in a Mouse Model of Helicobacter pylori Vaccination. | Int J Mol Sci | 2025 | 40869057 | PubTator, text mining | PubMed |
| Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation. | Transl Psychiatry | 2025 | 40849324 | PubTator, text mining | PubMed |
| The neuroreceptors and transporters underlying spontaneous brain activity. | Commun Biol | 2025 | 40738968 | PubTator, text mining | PubMed |
| Benchmarking 3D Structure-Based Molecule Generators. | J Chem Inf Model | 2025 | 40711830 | PubTator, text mining | PubMed |
| GPCR-A17 MAAP: mapping modulators, agonists, and antagonists to predict the next bioactive target. | J Cheminform | 2025 | 40646657 | PubTator, text mining | PubMed |
| Author Correction: Inhibition of serotonin-Htr2b signaling in skeletal muscle mitigates obesity-induced insulin resistance. | Exp Mol Med | 2025 | 40588531 | PubTator, text mining | PubMed |
| Discovery of a Novel, Potent, and Selective 5‑Hydroxytryptamine 2B Receptor Antagonist that Induces Mitochondrial Biogenesis in the Kidney. | ACS Pharmacol Transl Sci | 2025 | 40534670 | PubTator, text mining | PubMed |
| Residence time in drug discovery: current insights and future perspectives. | Pharmacol Rep | 2025 | 40489055 | PubTator, text mining | PubMed |
| Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling. | Int Immunopharmacol | 2025 | 40424654 | PubTator, text mining | PubMed |
| Activation of HTR2B Suppresses Osteosarcoma Progression through the STAT1-NLRP3 Inflammasome Pathway and Promotes OASL1+ Macrophage Production to Enhance Antitumor Immunity. | Adv Sci (Weinh) | 2025 | 40387572 | PubTator, text mining | PubMed |
| Efficacy and Tolerability of Viloxazine Compared to Placebo on Emotional, Behavioral, and Executive Functioning in Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis. | Neuropsychiatr Dis Treat | 2025 | 40386549 | PubTator, text mining | PubMed |
| Activity cliff-aware reinforcement learning for de novo drug design. | J Cheminform | 2025 | 40259427 | PubTator, text mining | PubMed |
| Repurposing serotonergic drugs for gastric cancer: induction of apoptosis in vitro. | Mol Biol Rep | 2025 | 40202572 | PubTator, text mining | PubMed |
| Mechanisms of constitutive and agonist-induced 5-HT2B internalization, persistent endosomal signaling and paradoxical regulation of agonist pharmacology. | Cell Signal | 2025 | 40169062 | PubTator, text mining | PubMed |
| Optimized 5-HT2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction. | Alzheimers Dement (N Y) | 2025 | 40151398 | PubTator, text mining | PubMed |
| A Comparison of the Treatment Effects of a Risperidone Solution, an Equal Ratio of DHA/ARA, and a Larger Ratio of Omega-6 PUFA Added to Omega-3 PUFA: An Open-Label Clinical Trial. | Curr Issues Mol Biol | 2025 | 40136438 | PubTator, text mining | PubMed |
| [Moxibustion Inhibits Postmenopausal Bone Loss by Regulating the Metabolism of Gut Microbiota-Related Serotonin]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 40109464 | PubTator, text mining | PubMed |
| Serotonin 3 receptor antagonism reduces angiotensin II-induced abdominal aortic aneurysms: Contribution of periaortic fat-derived serotonin. | J Pharmacol Exp Ther | 2025 | 40023595 | PubTator, text mining | PubMed |
| [5-HT Promotes Proliferation and Inhibits Apoptosis of Megakarycytes through 5-HT2BR]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40017189 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3357/papers?page=4